Our in-house accessibility experts specialize in testing and ensuring that anyone can access and use our clients’ websites, applications, and electronic documents. A recent amendment to the Rehabilitation Act of 1973, Section 508 was created to mandate this accessibility among U.S. Military, as well as State and Federal Government users.

The Lighthouse provides Section 508 Compliance and Accessibility Testing to ensure that all electronic and information technology (IT) systems, including websites, which are developed, procured, maintained or used by the Federal Government, are accessible to people with disabilities.

508 Conformance and Usability Assessment: 

  • Determine, evaluate, and report on clients’ web-based applications, software, websites, and electronic documents for conformance, accessibility, and usability by individuals with disabilities.
  • Identify deficiencies and provide recommendations for remediation – i.e. process changes, use of alternative tools, or systemic application modifications.
  • Re-assessment, re-testing, and evaluation of remediation activities.
  • Training and usability system development.
A graphic reading

Related Articles

  • Safe Travel Grant Provides Opportunities for Lighthouse Employees

    Over the past two years The Lighthouse for the Blind, Inc. has implemented services under the Housing and Urban Development Neighborhood Initiative Safe Travel Grant.  The grant provides a range of services, equipment, and supports [...]

  • Lighthouse employees ask: “How do I know if the iPhone is right for me?”

    Courtesy of  Julie Brannon, ECS Support Services Manager "How do I know if the iPhone is right for me?"  These were the exact words I heard from many Lighthouse employees in our monthly shop meetings [...]

  • Taking Steps Toward Accessible Prescription Drug Labeling Legislation

    Last year, Ameican Council of the Blind's Director of Advocacy and Governmental Affairs, Eric Bridges, worked in conjunction with the Office of Congresswoman McMorris-Rodgers on promoting H.R 4087, the Prescription Drug Labeling Promotion Act of 2012, [...]